U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2064120641The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory SymptomsNot yet recruitingNo Results AvailableAsthmaDrug: Qvar (100 mcg)https://ClinicalTrials.gov/show/NCT02294279
2064220642Mephedrone and Alcohol Interactions in HumansRecruitingNo Results AvailableAmphetamine-Related Disorders|Alcohol-Related DisordersDrug: Mephedrone and alcohol|Drug: Mephedrone|Drug: Alcohol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02294266
2064320643Buprenorphine/Naloxone Stabilization and Induction Onto Injection NaltrexoneRecruitingNo Results AvailableOpioid DependenceDrug: Buprenorphine/naloxonehttps://ClinicalTrials.gov/show/NCT02294253
2064420644Effect of Energy Dense Biscuits in Undernourished Women on Birth Weight of Their NeonatesRecruitingNo Results AvailableBirth WeightDietary Supplement: Energy dense biscuits|Other: Wheat Flour, oil, iron & Folic acidhttps://ClinicalTrials.gov/show/NCT02294240
206452064516-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic ArthritisRecruitingNo Results AvailableArthritis, PsoriaticBiological: Secukinumab|Biological: Secukinumab|Biological: Placebohttps://ClinicalTrials.gov/show/NCT02294227
2064620646Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - TanzaniaNot yet recruitingNo Results AvailableMalariaDevice: Spatial Repellent product with active ingredienthttps://ClinicalTrials.gov/show/NCT02294214
2064720647Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - KenyaNot yet recruitingNo Results AvailableMalariaDevice: Spatial Repellent product with active ingredienthttps://ClinicalTrials.gov/show/NCT02294201
2064820648Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - IndonesiaNot yet recruitingNo Results AvailableMalariaDevice: Spatial Repellent product with active ingredient (SHIELD)https://ClinicalTrials.gov/show/NCT02294188
2064920649Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm From Chronic Diabetic Foot UlcersRecruitingNo Results AvailableDiabetic Foot Ulcers|Bacterial InfectionDevice: Larval Debridement Therapy|Procedure: Bedside Sharp Debridementhttps://ClinicalTrials.gov/show/NCT02294175
2065020650Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?RecruitingNo Results AvailableNasal ObstructionDrug: Ketamine i.vhttps://ClinicalTrials.gov/show/NCT02294162
2065120651Vit D3 and Omega 3 in Chemo Induced NeuropathyRecruitingNo Results AvailableCancer|NeuropathyDrug: mammalian Omega 3 Fatty acids|Drug: placebohttps://ClinicalTrials.gov/show/NCT02294149
2065220652Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV CoinfectionRecruitingNo Results AvailableHIV|Hepatitis C|Co-InfectionBehavioral: Prep-C|Behavioral: Educational Controlhttps://ClinicalTrials.gov/show/NCT02294136
2065320653Glycemic Index and Insulinemic Index of 3 Types of Tortilla in Mexican AdultsEnrolling by invitationNo Results AvailableDiabetes|Overweight|HealthyOther: 3 tortillas and white breadhttps://ClinicalTrials.gov/show/NCT02294123
2065420654Effect of Diabetes Mellitus on Success of Spinal AnesthesiaCompletedNo Results AvailableDiabetes MellitusOther: spinal anesthesiahttps://ClinicalTrials.gov/show/NCT02294110
2065520655Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney TransplantationRecruitingNo Results AvailableSurveillance Protocol BiopsyProcedure: Surveillance protocol kidney allograft biopsyhttps://ClinicalTrials.gov/show/NCT02294097
2065620656Sitagliptin and Brown Adipose TissueNot yet recruitingNo Results AvailableNeoplasms, Adipose TissueDrug: Sitagliptin|Drug: placebohttps://ClinicalTrials.gov/show/NCT02294084
2065720657Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile ChildrenNot yet recruitingNo Results AvailableFeverDrug: Ibuprofen|Drug: Acetaminophenhttps://ClinicalTrials.gov/show/NCT02294071
2065820658Phase 3 Study of RPC1063 in Relapsing MSRecruitingNo Results AvailableMultiple SclerosisDrug: RPC1063|Drug: Beta interferonhttps://ClinicalTrials.gov/show/NCT02294058
2065920659Analysis of Joint Sounds in the Diagnosis of Knee DisordersNot yet recruitingNo Results AvailableHealthy Patients|No Knee Complaints|No Knee Injuries|No Knee Surgeries|No Neurological Problems|Patients Undergoing Knee Arthroscopy, Who Has a Pre-op MRI|Age Groups of 20,40 and 60 Years of Age.https://ClinicalTrials.gov/show/NCT02294045
2066020660The Role of B Cells in Kidney Allograft DysfunctionRecruitingNo Results AvailableKidney; Complications, Allograft|Transplantation InfectionDrug: Immunosuppressive Agentshttps://ClinicalTrials.gov/show/NCT02294032
2066120661Actual Use Trial of Ibuprofen 400 mgCompletedNo Results AvailablePatient ComplianceDrug: Ibuprofen 400 mg caplethttps://ClinicalTrials.gov/show/NCT02294019
2066220662Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETsRecruitingNo Results AvailableWell Differentiated Pancreatic Endocrine TumorDrug: Everolimus plus Octreotide LAR plus Metforminhttps://ClinicalTrials.gov/show/NCT02294006
2066320663Phase 1 Study of SGI-110 in Patients With Acute Myeloid LeukemiaRecruitingNo Results AvailableAcute Myeloid LeukemiaDrug: SGI-110https://ClinicalTrials.gov/show/NCT02293993
2066420664A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell CarcinomaRecruitingNo Results AvailableccRCC|RCC|Kidney Cancer|Clear Cell Renal Cell Carcinoma|Renal Cell CarcinomaDrug: PT2385 Tabletshttps://ClinicalTrials.gov/show/NCT02293980
2066520665Mass Balance Study of MT-1303CompletedNo Results AvailableRelapsing-remitting Multiple SclerosisDrug: MT-1303https://ClinicalTrials.gov/show/NCT02293967
2066620666Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerRecruitingNo Results AvailableBreast Cancer|Colon Cancer|Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastrointestinal Cancer|Liver and Intrahepatic Biliary Tract Cancer|Lung Cancer|Metastatic Cancer|Pancreatic Cancer|Rectal Cancer|Thyroid Gland Medullary Carcinoma|Unspecified AduProcedure: radionuclide imaging|Procedure: positron emission tomography|Other: laboratory biomarker analysis|Other: pharmacological study|Drug: Cu 64 anti-CEA monoclonal antibody M5A IVhttps://ClinicalTrials.gov/show/NCT02293954
2066720667Liver Test Study of Using JKB-122 in HCV-Positive PatientsRecruitingNo Results AvailableChronic Hepatitis CDrug: JKB-122|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02293941
2066820668Impact of Hybrid Coronary Revascularization on Antiplatelet TherapyCompletedNo Results AvailableCoronary Artery DiseaseProcedure: Hybrid coronary revascularizationhttps://ClinicalTrials.gov/show/NCT02293928
2066920669An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's DiseaseRecruitingNo Results AvailableMild to Moderate Alzheimer Disease|Cognitive ImpairmentDrug: Sodium oligo-mannurarate 900mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02293915
2067020670A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)RecruitingNo Results AvailableRheumatoid ArthritisDrug: sarilumab SAR153191 (REGN88)|Other: placebo|Drug: methotrexate|Drug: folic acidhttps://ClinicalTrials.gov/show/NCT02293902

* Görseller ve İçerik tekif hakkına sahip olabilir